HLA-C and neoplasm: Innate immunity mediated by NK cells is reportedly critical for attacking tumors, especially when acquired immunity is exhausted and dysfunctional [37, 38], and tumor cells express no or rare MHC necessary for the induction and activation of T cells [39].